Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 30 h ago

Yarrow Bioscience, Inc.: PERCEPTIVE ADVISORS LLC amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Perceptive Advisors LLC amended its Schedule 13G filing for Yarrow Bioscience, Inc., updating its beneficial ownership stake with the SEC under accession number 0001193125-26-463818. The amendment signals a change in the institutional investor's position in the biotech company, though the filing did not disclose the exact size of the stake or the direction of the move. Schedule 13G amendments are typically filed by passive investors when their ownership crosses or adjusts relative to the 5% threshold. Investors will watch for further disclosures to clarify whether Perceptive increased or trimmed its holding in Yarrow.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Perceptive Advisors LLC, Yarrow Bioscience, Inc.